Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zimmer Biomet Holdings (ZBH)

Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,579,622
  • Shares Outstanding, K 199,074
  • Annual Sales, $ 7,394 M
  • Annual Income, $ 1,024 M
  • EBIT $ 1,830 M
  • EBITDA $ 2,782 M
  • 60-Month Beta 1.02
  • Price/Sales 2.95
  • Price/Cash Flow 9.02
  • Price/Book 1.76

Options Overview Details

View History
  • Implied Volatility 22.55% ( +1.00%)
  • Historical Volatility 25.46%
  • IV Percentile 50%
  • IV Rank 21.28%
  • IV High 39.35% on 08/05/24
  • IV Low 18.01% on 03/19/24
  • Put/Call Vol Ratio 0.64
  • Today's Volume 393
  • Volume Avg (30-Day) 318
  • Put/Call OI Ratio 1.29
  • Today's Open Interest 16,342
  • Open Int (30-Day) 16,013

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.30
  • Number of Estimates 13
  • High Estimate 2.34
  • Low Estimate 2.26
  • Prior Year 2.20
  • Growth Rate Est. (year over year) +4.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
106.75 +0.15%
on 12/11/24
114.72 -6.81%
on 11/18/24
-2.55 (-2.33%)
since 11/11/24
3-Month
101.47 +5.36%
on 10/09/24
114.72 -6.81%
on 11/18/24
+1.76 (+1.67%)
since 09/11/24
52-Week
101.47 +5.36%
on 10/09/24
133.90 -20.16%
on 03/28/24
-11.07 (-9.38%)
since 12/11/23

Most Recent Stories

More News
Is Wall Street Bullish or Bearish on Zimmer Biomet Stock?

While Zimmer Biomet has lagged behind the broader market over the past year, analysts continue to hold a moderately positive view on the stock's prospects.

ZBH : 106.91 (-1.37%)
ZBH : 106.91 (-1.37%)
$SPX : 6,084.19 (+0.82%)
$SPX : 6,084.19 (+0.82%)
IHI : 60.23 (-0.10%)
IHI : 60.23 (-0.10%)
ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. Yet, factors like macroeconomic uncertainties put pressure on the bottom line. The stock...

ZBH : 106.91 (-1.37%)
GMED : 82.94 (+0.06%)
BSX : 90.56 (+0.40%)
RMD : 245.78 (+0.23%)
Zimmer: Q3 Earnings Snapshot

Zimmer: Q3 Earnings Snapshot

ZBH : 106.91 (-1.37%)
Here's What to Expect From Zimmer Biomet Holdings' Next Earnings Report

Zimmer Biomet Holdings is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings growth.

ZBH : 106.91 (-1.37%)
ZBH : 106.91 (-1.37%)
XLV : 142.14 (-1.36%)
$SPX : 6,084.19 (+0.82%)
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions,...

ZBH : 106.91 (-1.37%)
SNN : 25.76 (+0.31%)
SYK : 376.16 (-1.70%)
MDT : 82.92 (-0.79%)
3 Unusually Active Options to Play America’s Most Undervalued Stocks

Morningstar recently ranked the 10 most undervalued stocks to buy in October. I found three unusually active options that stood out as attractive bets on these struggling stocks.

BUD : 52.38 (-1.10%)
ZBH : 106.91 (-1.37%)
PII : 65.16 (-1.29%)
BTI : 37.74 (+0.03%)
EL : 81.22 (-1.65%)
NKE : 78.85 (+2.75%)
YUMC : 49.45 (+0.77%)
RTO : 26.83 (+1.86%)
RHHBY : 36.0000 (+1.01%)
PFE : 25.23 (-1.33%)
Is Solventum Stock Outperforming the Nasdaq?

Solventum outperformed the broader market recently, but Wall Street analysts remain cautious about the stock’s prospects.

SOLV : 70.49 (+1.10%)
ZBH : 106.91 (-1.37%)
$NASX : 20,034.89 (+1.77%)
Is STERIS Stock Underperforming the S&P 500?

STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.

STE : 209.62 (-2.15%)
STE : 209.62 (-2.15%)
$SPX : 6,084.19 (+0.82%)
ZBH : 106.91 (-1.37%)
ZBH : 106.91 (-1.37%)
Zimmer Biomet Stock: Is ZBH Underperforming the Healthcare Sector?

Zimmer Biomet has underperformed the healthcare sector over the past year, yet analysts remain moderately bullish about the stock’s prospects.

ZBH : 106.91 (-1.37%)
ZBH : 106.91 (-1.37%)
XLV : 142.14 (-1.36%)
MDT : 82.92 (-0.79%)
Stocks Finish Mostly Lower Ahead of Friday’s US Payroll Report

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.05%. Stocks on Thursday...

$SPX : 6,084.19 (+0.82%)
SPY : 607.46 (+0.77%)
$DOWI : 44,148.56 (-0.22%)
DIA : 442.51 (-0.27%)
$IUXX : 21,763.98 (+1.85%)
QQQ : 529.92 (+1.79%)
ZNH25 : 110-190 (-0.08%)
MCK : 576.69 (-1.24%)
ZBH : 106.91 (-1.37%)
CPRT : 62.61 (+1.77%)
HPE : 21.91 (-0.05%)
ODFL : 204.81 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products....

See More

Key Turning Points

3rd Resistance Point 110.51
2nd Resistance Point 109.72
1st Resistance Point 108.32
Last Price 106.91
1st Support Level 106.13
2nd Support Level 105.34
3rd Support Level 103.94

See More

52-Week High 133.90
Fibonacci 61.8% 121.51
Fibonacci 50% 117.68
Fibonacci 38.2% 113.86
Last Price 106.91
52-Week Low 101.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar